These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

221 related items for PubMed ID: 18440835

  • 1. Adjuvant chemotherapy in lymph node positive bladder cancer.
    Gofrit ON, Stadler WM, Zorn KC, Lin S, Silvestre J, Shalhav AL, Zagaja GP, Steinberg GD.
    Urol Oncol; 2009; 27(2):160-4. PubMed ID: 18440835
    [Abstract] [Full Text] [Related]

  • 2. Effectiveness of adjuvant chemotherapy in transitional cell carcinoma of the urinary bladder with lymph node involvement and/or lymphovascular invasion treated by radical cystectomy.
    Park J, Park S, Song C, Doo C, Cho YM, Ahn H, Kim CS.
    Urology; 2007 Aug; 70(2):257-62. PubMed ID: 17826485
    [Abstract] [Full Text] [Related]

  • 3. Outcomes of radical cystectomy for transitional cell carcinoma of the bladder: a contemporary series from the Bladder Cancer Research Consortium.
    Shariat SF, Karakiewicz PI, Palapattu GS, Lotan Y, Rogers CG, Amiel GE, Vazina A, Gupta A, Bastian PJ, Sagalowsky AI, Schoenberg MP, Lerner SP.
    J Urol; 2006 Dec; 176(6 Pt 1):2414-22; discussion 2422. PubMed ID: 17085118
    [Abstract] [Full Text] [Related]

  • 4. Role of lymph node density in predicting survival of patients with lymph node metastases after radical cystectomy: a multi-institutional study.
    Osawa T, Abe T, Shinohara N, Harabayashi T, Sazawa A, Kubota K, Matsuno Y, Shibata T, Shinno Y, Kamota S, Minami K, Sakashita S, Kumagai A, Mori T, Nonomura K.
    Int J Urol; 2009 Mar; 16(3):274-8; discussion 278. PubMed ID: 19087211
    [Abstract] [Full Text] [Related]

  • 5. Prognostic significance of adjuvant cisplatin-based combination chemotherapy following radical cystectomy in patients with invasive bladder cancer.
    Muramaki M, Miyake H, Kurahashi T, Takenaka A, Inoue TA, Fujisawa M.
    Int J Urol; 2008 Apr; 15(4):314-8. PubMed ID: 18380818
    [Abstract] [Full Text] [Related]

  • 6. Lymph node density is superior to TNM nodal status in predicting disease-specific survival after radical cystectomy for bladder cancer: analysis of pooled data from MDACC and MSKCC.
    Kassouf W, Agarwal PK, Herr HW, Munsell MF, Spiess PE, Brown GA, Pisters L, Grossman HB, Dinney CP, Kamat AM.
    J Clin Oncol; 2008 Jan 01; 26(1):121-6. PubMed ID: 18165646
    [Abstract] [Full Text] [Related]

  • 7. [Multivariate evaluation of survival factors and postoperative adjuvant chemotherapy in patients with bladder cancer treated by radical cystectomy].
    Takashi M, Murase T, Aota Y, Nagai T, Kinjo T, Sabashi M, Shimoji T, Miyake K, Hamajma N, Mizuno S.
    Hinyokika Kiyo; 1988 Aug 01; 34(8):1377-81. PubMed ID: 2461643
    [Abstract] [Full Text] [Related]

  • 8. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy.
    Bruins HM, Huang GJ, Cai J, Skinner DG, Stein JP, Penson DF.
    J Urol; 2009 Nov 01; 182(5):2182-7. PubMed ID: 19758623
    [Abstract] [Full Text] [Related]

  • 9. Impact of adjuvant systemic chemotherapy on postoperative survival in patients with high-risk urothelial cancer.
    Suzuki S, Shinohara N, Harabayashi T, Sato S, Abe T, Koyanagi T.
    Int J Urol; 2004 Jul 01; 11(7):456-60. PubMed ID: 15242352
    [Abstract] [Full Text] [Related]

  • 10. Complete long-term survival data from a trial of adjuvant chemotherapy vs control after radical cystectomy for locally advanced bladder cancer.
    Lehmann J, Franzaring L, Thüroff J, Wellek S, Stöckle M.
    BJU Int; 2006 Jan 01; 97(1):42-7. PubMed ID: 16336326
    [Abstract] [Full Text] [Related]

  • 11. Evaluation of the relevance of lymph node density in a contemporary series of patients undergoing radical cystectomy.
    Kassouf W, Leibovici D, Munsell MF, Dinney CP, Grossman HB, Kamat AM.
    J Urol; 2006 Jul 01; 176(1):53-7; discussion 57. PubMed ID: 16753366
    [Abstract] [Full Text] [Related]

  • 12. Positive surgical margins in soft tissue following radical cystectomy for bladder cancer and cancer specific survival.
    Dotan ZA, Kavanagh K, Yossepowitch O, Kaag M, Olgac S, Donat M, Herr HW.
    J Urol; 2007 Dec 01; 178(6):2308-12; discussion 2313. PubMed ID: 17936804
    [Abstract] [Full Text] [Related]

  • 13. Combination chemotherapy of ifosfamide, 5-fluorouracil, etoposide and cisplatin as perioperative treatment in lymph node positive bladder carcinoma patients treated by radical cystectomy.
    Komai Y, Fujii Y, Okubo Y, Yamamoto S, Kawakami S, Yonese J, Fukui I.
    Int J Urol; 2008 Oct 01; 15(11):971-5. PubMed ID: 18775029
    [Abstract] [Full Text] [Related]

  • 14. Surgical factors influence bladder cancer outcomes: a cooperative group report.
    Herr HW, Faulkner JR, Grossman HB, Natale RB, deVere White R, Sarosdy MF, Crawford ED.
    J Clin Oncol; 2004 Jul 15; 22(14):2781-9. PubMed ID: 15199091
    [Abstract] [Full Text] [Related]

  • 15. The association between extent of lymphadenectomy and survival among patients with lymph node metastases undergoing radical cystectomy.
    Wright JL, Lin DW, Porter MP.
    Cancer; 2008 Jun 15; 112(11):2401-8. PubMed ID: 18383515
    [Abstract] [Full Text] [Related]

  • 16. Lymphadenectomy in bladder cancer: how high is "high enough"?
    Stein JP.
    Urol Oncol; 2006 Jun 15; 24(4):349-55. PubMed ID: 16818190
    [Abstract] [Full Text] [Related]

  • 17. Clinical outcome of radical cystectomy for patients with pT4 bladder cancer.
    Furukawa J, Miyake H, Hara I, Takenaka A, Fujisawa M.
    Int J Urol; 2008 Jan 15; 15(1):58-61. PubMed ID: 18184174
    [Abstract] [Full Text] [Related]

  • 18. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E, Stöter E, van Ophoven A, Bierer S, Bolenz C, Hertle L, Wülfing C.
    Int J Urol; 2008 Jul 15; 15(7):607-11. PubMed ID: 18462352
    [Abstract] [Full Text] [Related]

  • 19. Outcomes and prognostic factors in patients with a single lymph node metastasis at time of radical cystectomy.
    Rink M, Hansen J, Cha EK, Green DA, Babjuk M, Svatek RS, Xylinas E, Tagawa ST, Faison T, Novara G, Karakiewicz PI, Daneshmand S, Lotan Y, Kassouf W, Fritsche HM, Pycha A, Comploj E, Tilki D, Bastian PJ, Chun FK, Dahlem R, Scherr DS, Shariat SF.
    BJU Int; 2013 Jan 15; 111(1):74-84. PubMed ID: 22809039
    [Abstract] [Full Text] [Related]

  • 20. A multicenter evaluation of sequential multimodality therapy and clinical outcome for the treatment of advanced endometrial cancer.
    Secord AA, Havrilesky LJ, O'Malley DM, Bae-Jump V, Fleming ND, Broadwater G, Cohn DE, Gehrig PA.
    Gynecol Oncol; 2009 Sep 15; 114(3):442-7. PubMed ID: 19560193
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.